End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.83 CNY | +1.10% | +9.46% | +28.12% |
08/05 | CR Double-Crane Pharmaceutical's Unit Gets Nod for Lidocaine Hydrochloride Injection | MT |
26/04 | CR Double-Crane Pharmaceutical's Profit Rises 11% in Q1 as Revenue Grows 2% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+28.12% | 333.05Cr | |
+29.38% | 68TCr | |
+30.34% | 57TCr | |
-4.02% | 36TCr | |
+17.70% | 33TCr | |
+3.91% | 28TCr | |
+16.21% | 24TCr | |
+9.66% | 21TCr | |
-6.83% | 20TCr | |
+6.73% | 17TCr |
- Stock Market
- Equities
- 600062 Stock
- News China Resources Double-Crane Pharmaceutical Co.,Ltd.
- CR Double-Crane Pharma Unit's Brain Drug Passes Regulator's Evaluation